Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine administered concomitantly with measles, mumps, rubella, varicella vaccine in healthy toddlers-Reference-Cited by-同舟云学术

Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine administered concomitantly with measles, mumps, rubella, varicella vaccine in healthy toddlers

Published:2012-06 Issue:26 Volume:30 Page:3929-3936
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Klein Nicola P.,Shepard Julie,Bedell Lisa,Odrljin Tatjana,Dull Peter

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference15 articles.

1. A surveillance network for meningococcal disease in Europe;Trotter;FEMS Microbiology Review,2007

2. Prevention and control of meningococcal disease: recommendations for use of meningococcal vaccines in pediatric patients;American Academy of Pediatrics Committee on Infectious Diseases;Pediatrics,2005

3. Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meninogococcal polysaccharide diphtheria toxoid conjugate vaccine in infants;Rennels;Pediatric Infectious Disease Journal,2004

4. Safety and immunogenicity of a novel quadrivalent meningococcal CRM-conjugate vaccine given concomitantly with routine vaccinations in infants;Klein;Pediatric Infectious Disease Journal,2012

5. Notice to readers: licensure of a combined live attenuated measles, mumps, rubella, and varicella vaccine;Centers for Disease Control and Prevention (CDC);Morbidity and Mortality Weekly Report,2005

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of a mumps containing vaccine in preventing laboratory-confirmed mumps cases from 2002 to 2017: A meta-analysis;Open Life Sciences;2024-01-01

2. A phase II, single-center, randomized, double-blind, parallel control clinical study evaluating the immunogenicity and safety of a two-dose schedule of serogroups ACYW meningococcal polysaccharide conjugate vaccine;Vaccine;2022-11

3. Safety and immunogenicity of an investigational quadrivalent meningococcal tetanus toxoid conjugate vaccine (MenACYW-TT) co-administered with routine pediatric vaccines in infants and toddlers: A Phase II study;Vaccine;2022-03

4. A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine;Infectious Diseases and Therapy;2021-09-30

5. Genetic associations with a fever after measles-containing vaccines;Human Vaccines & Immunotherapeutics;2020-12-22